Percutaneous coronary intervention in a patient with acute non-ST-elevation myocardial infarction and haemophilia A: a 'genous' experience.

Standard treatment of Acute Coronary Syndromes (ACS) involves primary coronary angioplasty (PTCA) with stent implantation. Accordingly, double antiplatelet therapy (DAT) is indicated for prevention of stent thrombosis but is associated with increased bleeding risk. Prevalence of coronary artery disease (CAD) as well as of ACS in patients with haemophilia is currently increasing. Simultaneously, PTCA and the need for DAT are also increasing. In this study, we describe the case of a young patient with severe haemophilia and chronic HIV/HCV infection who developed chest pain as a result of non-ST elevation myocardial infarction (NSTEMI). He was treated with PTCA and a newer stent which did non require DAT for no more that ten days.